Tag Archives: Moss Genomics

Vancouver, British Columbia–(Newsfile Corp. – July 10, 2025) – Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the “Company” or “Moss”) is providing an update on its Ethereum (ETH) Treasury Strategy. As part of this strategy, the Company has contributed 200 ETH with a commitment to contribute an additional 800 ETH to …

Vancouver, British Columbia–(Newsfile Corp. – June 19, 2025) – Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (OTCQB: MSSGF) (the “Company” or “Moss”) is pleased to announce that on June 18, 2025, it has entered into a non-binding term sheet for a strategic, non-controlling equity investment in Genomes.io Ltd. (“Genomes.io”), a UK-based …

Vancouver, British Columbia–(Newsfile Corp. – April 11, 2025) – Moss Genomics Inc. (CSE: MOSS) (OTCQB: MSSGF) (FSE: F73) (the “Company” or “Moss”) is pleased to announce that its common shares are now listed for trading on the OTC Markets under the ticker MSSGF. This milestone significantly expands Moss’s accessibility for …

Vancouver, British Columbia–(Newsfile Corp. – February 26, 2025) – Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (“Moss” or the “Company”) is pleased to announce the appointment of Joseph De Pinto to its Board of Directors and Michal “Mickey” Goldstein as its new fractional Chief Financial Officer (CFO). Having served as …

Vancouver, British Columbia–(Newsfile Corp. – February 25, 2025) – Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the “Company” or “Moss Genomics”) is pleased to provide an update on its business strategy and the continued development of its genomics-focused initiatives. As the Company advances its product roadmap, it remains committed to …

Vancouver, British Columbia–(Newsfile Corp. – February 3, 2025) – Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the “Company” or “Moss”) is pleased to announce a non-brokered private placement of up to 2,000,000 common shares at price of $0.18 per share for aggregate proceeds of up to $360,000 (the “Offering”). The …

Vancouver, British Columbia–(Newsfile Corp. – January 31, 2025) – Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the “Company” or “Moss”) is pleased to announce that is has closed its previously announced non-brokered private placement of 2,500,000 common shares (each a “Share”) at $0.10 per Share for total gross proceeds of …

Vancouver, British Columbia–(Newsfile Corp. – January 24, 2025) – Moss Genomics Inc. (CSE: MOSS) (FSE: F73) (the “Company” or “Moss”) is pleased to provide an update on the Company’s operations and business strategy. Corporate Update Further to the Company’s news release dated December 24, 2024, the Company anticipates closing its …